IRIS Accounts Production v24.1.4.33 09287544 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh092875442023-03-31092875442024-03-31092875442023-04-012024-03-31092875442022-03-31092875442022-04-012023-03-31092875442023-03-3109287544ns15:EnglandWales2023-04-012024-03-3109287544ns14:PoundSterling2023-04-012024-03-3109287544ns10:Director12023-04-012024-03-3109287544ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3109287544ns10:SmallEntities2023-04-012024-03-3109287544ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3109287544ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3109287544ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3109287544ns10:FullAccounts2023-04-012024-03-3109287544ns10:Director22023-04-012024-03-3109287544ns10:RegisteredOffice2023-04-012024-03-3109287544ns5:CurrentFinancialInstruments2024-03-3109287544ns5:CurrentFinancialInstruments2023-03-3109287544ns5:ShareCapital2024-03-3109287544ns5:ShareCapital2023-03-3109287544ns5:RetainedEarningsAccumulatedLosses2024-03-3109287544ns5:RetainedEarningsAccumulatedLosses2023-03-3109287544ns5:FurnitureFittings2023-04-012024-03-3109287544ns5:ComputerEquipment2023-04-012024-03-3109287544ns5:PlantMachinery2023-03-3109287544ns5:PlantMachinery2023-04-012024-03-3109287544ns5:PlantMachinery2024-03-3109287544ns5:PlantMachinery2023-03-3109287544ns5:CostValuation2023-03-3109287544ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3109287544ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-31
REGISTERED NUMBER: 09287544 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

AVB ONCOLOGY LIMITED

AVB ONCOLOGY LIMITED (REGISTERED NUMBER: 09287544)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


AVB ONCOLOGY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: Mr A Y Bhatnagar
Mrs V A Bhatnagar





REGISTERED OFFICE: 28a The Hundred
Romsey
Hampshire
SO51 8BW





REGISTERED NUMBER: 09287544 (England and Wales)





ACCOUNTANTS: Kumar Associates
Chartered Certified Accountants
28a The Hundred
Romsey
Hampshire
SO51 8BW

AVB ONCOLOGY LIMITED (REGISTERED NUMBER: 09287544)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,028 2,693
Investments 5 35,000 35,000
37,028 37,693

CURRENT ASSETS
Debtors 6 8,610 5,103
Cash at bank 101,778 93,596
110,388 98,699
CREDITORS
Amounts falling due within one year 7 34,193 34,507
NET CURRENT ASSETS 76,195 64,192
TOTAL ASSETS LESS CURRENT
LIABILITIES

113,223

101,885

CAPITAL AND RESERVES
Called up share capital 150 150
Retained earnings 113,073 101,735
SHAREHOLDERS' FUNDS 113,223 101,885

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 July 2024 and were signed on its behalf by:



Mr A Y Bhatnagar - Director


AVB ONCOLOGY LIMITED (REGISTERED NUMBER: 09287544)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1. STATUTORY INFORMATION

AVB Oncology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Computer equipment - 50% on reducing balance

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2023 13,630
Additions 1,099
At 31 March 2024 14,729
DEPRECIATION
At 1 April 2023 10,937
Charge for year 1,764
At 31 March 2024 12,701
NET BOOK VALUE
At 31 March 2024 2,028
At 31 March 2023 2,693

AVB ONCOLOGY LIMITED (REGISTERED NUMBER: 09287544)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 April 2023
and 31 March 2024 35,000
NET BOOK VALUE
At 31 March 2024 35,000
At 31 March 2023 35,000

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 2,110 5,103
Other debtors 6,500 -
8,610 5,103

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 28,806 12,953
Other creditors 5,387 21,554
34,193 34,507